论文部分内容阅读
目的观察沐舒坦雾化吸入对慢性阻塞性肺病急性加重期的治疗。方法选择COPD120例随机分为治疗组和对照组,治疗组用沐舒坦,对照组用生理盐水+糜蛋白酶+地塞米松,疗程均为一周。结果治疗组总有效率86.6%,对照组总有效率66.6%,组间差异有显著性(p<0.05)。结论沐舒坦雾化吸入对慢性阻塞性肺病急性加重期的治疗效果显著。
Objective To observe the therapeutic effect of mucosolvan inhalation on acute exacerbation of chronic obstructive pulmonary disease. Methods COPD120 cases were randomly divided into treatment group and control group, the treatment group with mucosolvan, the control group with saline + chymotrypsin + dexamethasone, treatment for one week. Results The total effective rate was 86.6% in the treatment group and 66.6% in the control group. There was significant difference between the two groups (p <0.05). Conclusion Mucosolvan inhalation is effective in the treatment of acute exacerbation of chronic obstructive pulmonary disease.